Value
4.4/10data confidence 67%| Component | Sub-score |
|---|---|
| P/S | 2.7 |
| Fwd P/E | 1.4 |
| PEG | 10.0 |
| Analyst target | 5.0 |
- ▸Forward P/E: 70.7x
- ▸PEG: 0.24
AXGN · Why this verdict
Why AxoGen (AXGN) is rated BUY WAIT
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictBUY WAIT
Overall score5.7/10
ConfidenceMEDIUM
MacroRISK_OFF
TrendMatrix Research · core thesis
Engine thesis — one sentence
AxoGen is an industry growth leader with 26% YoY revenue growth, positive free cash flow despite a GAAP loss and a wide moat. At $49.37 the price is only 2.8% below the $50.78 analyst target with RSI at 81, so the 0.19 reward-to-risk offers little room.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
The company is free-cash-flow positive despite a GAAP loss, with an FCF margin of 11%, a Piotroski score of 8/9 and gross margin at the maximum 10/10. Quality breakdown | Free cash flow margin should stay above 8% while GAAP profitability moves toward breakeven. | →Stable |
| CounterThe FCF yield is only 1.0%, and GAAP net margin and ROE score zero, so reported profitability is still weak. | ||
Axogen is an industry growth leader with strong revenue growth of 26% YoY, and the growth dimension scores 9.0/10. Growth breakdown | Revenue growth should stay above 18% YoY over the next 12 months. | ↓Deteriorating |
| CounterGrowth confidence is low (0.33) because only one metric is available, and a forward P/E of 70.0x requires growth to persist. | ||
The price of $49.37 is only 2.8% below the $50.78 analyst target against 15.0% downside to the stop, a reward-to-risk of 0.19. Estimated upside | Upside should reopen via target raises or a pullback toward the 50-day average near $42.86. | →Stable |
| CounterAnalyst rating scores 8.26/10 and positive news sentiment could drive target raises after the strong October beat. | ||
RSI is overbought at 81 although rising on-balance volume and price above the 200-day average show accumulation, with momentum scoring 7.2/10. Momentum breakdown | RSI should cool below 70 without losing the 200-day average. | ↑Improving |
| CounterRSI above 80 often precedes sharp pullbacks and Bollinger components score zero, indicating an extended price. | ||
Insiders sold $4.7M recently (0.158% of market cap), and earnings have been uneven, with one 59.9% beat, two inline results and a 27.9% miss in the last four quarters. Insider breakdown | Insider selling should stay below 0.2% of market cap and EPS surprises should stay non-negative. | →Stable |
| CounterInsider sales can reflect scheduled diversification, and the latest quarter's EPS of $0.21 beat by 59.9%. | ||
The company is free-cash-flow positive despite a GAAP loss, with an FCF margin of 11%, a Piotroski score of 8/9 and gross margin at the maximum 10/10.
→StableQuality breakdown
- Expectation
- Free cash flow margin should stay above 8% while GAAP profitability moves toward breakeven.
CounterThe FCF yield is only 1.0%, and GAAP net margin and ROE score zero, so reported profitability is still weak.
Axogen is an industry growth leader with strong revenue growth of 26% YoY, and the growth dimension scores 9.0/10.
↓DeterioratingGrowth breakdown
- Expectation
- Revenue growth should stay above 18% YoY over the next 12 months.
CounterGrowth confidence is low (0.33) because only one metric is available, and a forward P/E of 70.0x requires growth to persist.
The price of $49.37 is only 2.8% below the $50.78 analyst target against 15.0% downside to the stop, a reward-to-risk of 0.19.
→StableEstimated upside
- Expectation
- Upside should reopen via target raises or a pullback toward the 50-day average near $42.86.
CounterAnalyst rating scores 8.26/10 and positive news sentiment could drive target raises after the strong October beat.
RSI is overbought at 81 although rising on-balance volume and price above the 200-day average show accumulation, with momentum scoring 7.2/10.
↑ImprovingMomentum breakdown
- Expectation
- RSI should cool below 70 without losing the 200-day average.
CounterRSI above 80 often precedes sharp pullbacks and Bollinger components score zero, indicating an extended price.
Insiders sold $4.7M recently (0.158% of market cap), and earnings have been uneven, with one 59.9% beat, two inline results and a 27.9% miss in the last four quarters.
→StableInsider breakdown
- Expectation
- Insider selling should stay below 0.2% of market cap and EPS surprises should stay non-negative.
CounterInsider sales can reflect scheduled diversification, and the latest quarter's EPS of $0.21 beat by 59.9%.
Per-dimension breakdown
Quality
4.2/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 0.0 |
| ROA | 0.0 |
| Gross margin | 10.0 |
| Op margin | 0.5 |
| Net margin | 0.0 |
| Current ratio | 5.0 |
| FCF quality | 5.2 |
| Moat | 7.2 |
| Rule of 40 | 5.5 |
| Piotroski F | 8.9 |
- ▸FCF-positive despite GAAP loss (FCF margin 11%, FCF yield 1.0%)
- ▸Strong Piotroski F-Score: 8/9
Growth
9.0/10data confidence 33%| Component | Sub-score |
|---|---|
| Rev growth | 9.0 |
- ▸Strong growth: 26% YoY
Momentum
6.6/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 3.6 |
| MACD | 10.0 |
| OBV | 10.0 |
| MA position | 9.0 |
| Volume | 0.5 |
- ▸Overbought (RSI 88)
- ▸Volume accumulation (rising OBV)
- ▸Above 200-day MA
Sentiment
7.5/10data confidence 100%| Component | Sub-score |
|---|---|
| LLM sentiment | 6.5 |
| Analyst rating | 8.3 |
| Price target | 7.6 |
Insider
3.8/10data confidence 100%| Component | Sub-score |
|---|---|
| materiality | 3.0 |
| insider conviction | 2.0 |
| holder change | 5.0 |
| notable moves | 5.0 |
- ▸Notable insider selling — $4,657,286 (0.156% of mkt cap)
Peer rank
5.2/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 0.8 |
| quality rank | 3.1 |
| growth rank | 8.2 |
- ▸Industry growth leader
- ▸Conservative debt levels
Technical
3.9/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 0.8 |
| support resistance | 1.0 |
| 52w position | 8.7 |
| gap | 5.0 |
Risk (lower is worse)
5.6/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 5.1 |
| days to cover | 7.1 |
| volatility | 0.7 |
| put call | 10.0 |
| implied vol | 3.0 |
| beta | 6.4 |
| debt equity | 9.8 |
| news risk | 3.0 |
- ▸High IV: 62%
Catalyst
5.5/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 3.3 |
| earnings timing | 5.0 |
| surprise avg | 6.4 |
| news activity | 8.0 |
How the verdict was assembled
Engine trigger
Mixed signals. Hold existing position. | News modifier +1 (HOLD_IF_HOLDING → STRONG_BUY_WAIT).
Engine technical detail
verdict_path:
L4:PATH_F_HOLD_DEFAULT|L3:NEWS_MOD=+1|ENTRY_STICKY:WITHIN_BANDPassed (7)
- MOMENTUM:6.6>=5.5
- INSIDER:OK
- 8K:CLEAN
- NEWS_BOOST:ANALYST:0.70
- EARNINGS_PROXIMITY:111d clear
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
- ASYMMETRY:0.3<1.5@spot
Warning (0)
none
Reward-to-Risk
0.26
Upside
+3.9%
Downside
15.0%
Sizing output
STARTER
Setup— — No clear chart pattern; technical signals are mixed
EdgeNo clear edge — No clear edge identified
SuitabilityAggressive — MCap $3.0B<$5B
Investment implication
The default F-path HOLD fired without any positive-conviction gate triggering — no momentum acceleration, no quality+value crossover, no setup recognition. Highest-clear gate: MOMENTUM:6.6>=5.5. Top dim: Growth at 9.0; weakest: Insider at 3.8. The engine's read is one of pattern absence — no directional conviction in either direction at current asymmetry.
The strongest dimensions are Growth at 9.0, Sentiment at 7.5, and Momentum at 6.6; the weakest are Insider at 3.8, Technical at 3.9, and Quality at 4.2. The V9 engine flagged 1 failed gate, producing an asymmetric reward-to-risk of 0.26 and an engine sizing output of STARTER.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Industry Growth Leader
Trip ifRevenue growth falls below 15% YoY from current 26%.
- P2Fcf Positive Despite Gaap Loss
Trip ifFree cash flow margin falls below 5% from current 11%.
- P3Limited Upside To Analyst Target
Trip ifUpside to the analyst target exceeds 15% from current 2.8%.
- P4Overbought But Accumulating
Trip ifPrice falls below the 200-day average while RSI drops below 50 from current 81.
- P5Insider Selling Uneven Earnings
Trip ifInsider selling exceeds 0.5% of market cap from current 0.158%.